Effect of Cocaine and LTR Polymorphism on HIV-1 Pathogenesis
Effect of Cocaine and LTR Polymorphism on HIV-1 Pathogenesis
批准号:
8447113
负责人:
Richard B. Markham
金额:
$49.15万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-30 至 2014-09-30
关键词:
ATF2 geneAcuteAddressAnimal ModelAnti-Retroviral AgentsAntiretroviral resistanceAquilaBindingBinding SitesBiologicalBiological ModelsBrainCD4 Positive T LymphocytesCellsCharacteristicsCocaineCocaine AbuseCocaine UsersComplexConsensus SequenceDNADNA BindingDevelopmentDimerizationDisease ProgressionDrug abuseDrug usageDrug userElectrophoretic Mobility Shift AssayEventFOS geneFamilyFrequenciesGene ComponentsGene ExpressionGeneticGenetic PolymorphismGenetic TranscriptionGenetic VariationHIV-1HeterogeneityHomoIllicit DrugsImmediate-Early GenesIn VitroIndividualJUN geneLaboratory StudyLengthLeucine ZippersLinkLong Terminal RepeatsLymphocyteMicrogliaMolecularMultivariate AnalysisMutationOutcomePathogenesisPatientsPeptide HydrolasesPharmaceutical PreparationsPopulationProtease InhibitorProteinsRecording of previous eventsRegulationReportingResistanceSamplingSpecimenSurfaceSystemTechnologyTestingTimeTransactivationTranscription Factor AP-1VariantViralViral Load resultVirusWomanaddictionantiretroviral therapybasebrain cellclinical carecocaine exposurecocaine usecohortcytokinedimerdrug of abusein vivoinjection drug usemacrophagemedical schoolsmonocytenon-drugperipheral bloodpromoterpublic health relevanceresistance mutationtranscription factorvirus genetics
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Previous studies from this laboratory have demonstrated significantly higher viral genetic diversity and a higher frequency of primary resistance to protease inhibitors (PI) among illicit drug users compared to HIV-1 infected non-drug users. To explore the potential link between drug use and greater viral replication, diversity and antiretroviral resistance, we propose to exploit the findings that 1) cocaine abuse stimulates high levels of the AP-1 transcription factor associated immediate early genes and 2) only about 40% of Clade B infected individuals carry an HIV-1 LTR length polymorphism (MFNLP) containing an AP-1 binding site. Using a large cohort of cocaine using HIV-1 infected subjects followed at the Vanderbilt Clinical Care Center, we will address the hypothesis that cocaine users infected with HIV-1 carrying the Clade B HIV-1 LTR polymorphism with an AP-1 binding site will have higher viral loads, greater genetic diversity, and greater primary resistance to antiretrovirals than either cocaine users whose virus does not carry the LTR polymorphism or non-cocaine users. To explore this hypothesis we will 1) Identify among a cohort of HIV-1 positive, antiretroviral therapy naive individuals those cocaine-using and non-cocaine using individuals with virus carrying the MFNLP within the LTR. We will thereby have identified four groups for additional analyses: HIV-1 infected cocaine users with and without the MFNLP and non-cocaine users with and without the MFNLP. 2) Within the four groups quantify the expression levels within peripheral blood CD4 T lymphocytes and monocytes of c-fos and JunB, as representative immediate early gene components of AP-1. Similarly, using gel-shift assays or a new high throughput kit, we will quantify levels of AP-1 within those cell populations from the four groups. 3) Using 454 high throughput sequencing technology we will sequence the protease region to define within host genetic diversity and primary resistance mutations to PI. Using diversity, resistance mutations to PI and viral load as outcomes, we will examine using a multivariate analysis, the effect of cocaine use, immediate early gene expression levels, AP-1 quantities, and the presence of the MFNLP.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identification of novel anti-HIV inhibitors based on Vif-E3 activity
-
批准号:8713917
-
项目类别:
-
资助金额:$20.25万
-
财政年份:2013
-
负责人:Richard B. Markham
-
依托单位:
Roche 454 Genome Sequencer FLX
-
批准号:7794303
-
项目类别:
-
资助金额:$43.99万
-
财政年份:2010
-
负责人:Richard B. Markham
-
依托单位:
Development of transformed lactobacilli as a microbicide
-
批准号:7666631
-
项目类别:
-
资助金额:$19.97万
-
财政年份:2009
-
负责人:Richard B. Markham
-
依托单位:
Development of transformed lactobacilli as a microbicide
-
批准号:7800351
-
项目类别:
-
资助金额:$24.64万
-
财政年份:2009
-
负责人:Richard B. Markham
-
依托单位:
Use of clonal genotyping to predict resistance development in ART-naive IDU
-
批准号:8044183
-
项目类别:
-
资助金额:$57.9万
-
财政年份:2008
-
负责人:Richard B. Markham
-
依托单位:
Effect of Cocaine and LTR Polymorphism on HIV-1 Pathogenesis
-
批准号:7599468
-
项目类别:
-
资助金额:$55.67万
-
财政年份:2008
-
负责人:Richard B. Markham
-
依托单位:
Development of a Malaria DNA Vaccine with Enchanced Immunogenicity
-
批准号:7530124
-
项目类别:
-
资助金额:$24.6万
-
财政年份:2008
-
负责人:Richard B. Markham
-
依托单位:
Use of clonal genotyping to predict resistance development in ART-naive IDU
-
批准号:7805532
-
项目类别:
-
资助金额:$57.97万
-
财政年份:2008
-
负责人:Richard B. Markham
-
依托单位:
Effect of Cocaine and LTR Polymorphism on HIV-1 Pathogenesis
-
批准号:8257981
-
项目类别:
-
资助金额:$56.75万
-
财政年份:2008
-
负责人:Richard B. Markham
-
依托单位:
Effect of Cocaine and LTR Polymorphism on HIV-1 Pathogenesis
-
批准号:7691302
-
项目类别:
-
资助金额:$57.56万
-
财政年份:2008
-
负责人:Richard B. Markham
-
依托单位:
Use of clonal genotyping to predict resistance development in ART-naive IDU
-
批准号:7625170
-
项目类别:
-
资助金额:$56.87万
-
财政年份:2008
-
负责人:Richard B. Markham
-
依托单位:
Use of clonal genotyping to predict resistance development in ART-naive IDU
-
批准号:8247137
-
项目类别:
-
资助金额:$57.86万
-
财政年份:2008
-
负责人:Richard B. Markham
-
依托单位:
Effect of Cocaine and LTR Polymorphism on HIV-1 Pathogenesis
-
批准号:7849075
-
项目类别:
-
资助金额:$56.9万
-
财政年份:2008
-
负责人:Richard B. Markham
-
依托单位:
Use of clonal genotyping to predict resistance development in ART-naive IDU
-
批准号:7418766
-
项目类别:
-
资助金额:$56.83万
-
财政年份:2008
-
负责人:Richard B. Markham
-
依托单位:
Development of a Malaria DNA Vaccine with Enchanced Immunogenicity
-
批准号:7634429
-
项目类别:
-
资助金额:$20.5万
-
财政年份:2008
-
负责人:Richard B. Markham
-
依托单位:
Anti-ICAM-i scFv from lactobacilli as a Microbicide
-
批准号:6809151
-
项目类别:
-
资助金额:$47.21万
-
财政年份:2004
-
负责人:Richard B. Markham
-
依托单位:
Anti-ICAM-1 scFv from Lactobacilli as a Microbicide
-
批准号:6656068
-
项目类别:
-
资助金额:$21.35万
-
财政年份:2003
-
负责人:Richard B. Markham
-
依托单位:
Anti-ICAM-1 scFv from Lactobacilli as a Microbicide
-
批准号:6763171
-
项目类别:
-
资助金额:$19.76万
-
财政年份:2003
-
负责人:Richard B. Markham
-
依托单位:
DRUG ABUSE AND RESISTANCE TO ANTIRETROVIRAL THERAPY
-
批准号:6147658
-
项目类别:
-
资助金额:$35.76万
-
财政年份:2000
-
负责人:Richard B. Markham
-
依托单位:
DRUG ABUSE AND RESISTANCE TO ANTIRETROVIRAL THERAPY
-
批准号:6644727
-
项目类别:
-
资助金额:$36.79万
-
财政年份:2000
-
负责人:Richard B. Markham
-
依托单位:
海外基金